Heights Capital Management, Inc Reviva Pharmaceuticals Holdings, Inc. Transaction History
Heights Capital Management, Inc
- $375 Billion
- Q2 2025
A detailed history of Heights Capital Management, Inc transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Heights Capital Management, Inc holds 1,829,904 shares of RVPH stock, worth $823,456. This represents 0.19% of its overall portfolio holdings.
Number of Shares
1,829,904Holding current value
$823,456% of portfolio
0.19%Shares
1 transactions
Others Institutions Holding RVPH
# of Institutions
55Shares Held
14.5MCall Options Held
4.9MPut Options Held
29.7K-
Diadema Partners LP Morristown, NJ2.74MShares$1.23 Million0.32% of portfolio
-
Armistice Capital, LLC New York, NY2.69MShares$1.21 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$811,8410.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.49MShares$669,6190.0% of portfolio
-
683 Capital Management, LLC New York, NY1MShares$450,0000.03% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $9.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...